TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDXGlobe Newswire • about 1 month agoTELA Bio to receive at least $8 million and up to $12 million in total considerationMALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical...